Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Trends in Immunology   Volumes    Volume 15 
Adoptive T-cell therapy for metastatic melanoma
Courtney Regan, Michael Nishimura, Joseph I. Clark
Pages: 1 - 8
Number of pages: 8
Current Trends in Immunology
Volume 15 

Copyright © 2014 Research Trends. All rights reserved

Immunotherapy has changed the face of cancer treatment in metastatic melanoma. Clinical trials using tumor infiltrating lymphocytes (TIL) to recognize and mediate regression of tumor cells have demonstrated objective responses. One of the limitations of TIL is the inability to access tumors in patients or the presence of too few tumor infiltrating lymphocytes present in the tumors once resected. This has stimulated researchers to engineer methods to convert normal lymphocytes into tumor targeted T-cells. One method of doing so is through genetic modification of peripheral autologous lymphocytes with genes encoding T-cell receptors. Genetically engineered T-cells can broaden the opportunity for the use of T-cell immunotherapy in melanoma and other cancer patients. It also offers the possibility of improving the T-cell efficacy with the introduction of additional genes giving them an advantage over TIL.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms